Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response

Gut dysbiosis has been reported in chronic hepatitis B (CHB) infection, however its role in CHB progression and antiviral treatment remains to be clarified. Herein, the present study aimed to characterize gut microbiota (GM) in patients with chronic hepatitis B virus infection-associated liver disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yue, Wu, Sheng-Di, Chen, Yao, Li, Xin-Yue, Zhu, Qin, Nakayama, Kiyoko, Zhang, Wan-Qin, Weng, Cheng-Zhao, Zhang, Jun, Wang, Hai-Kun, Wu, Jian, Jiang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757487/
https://www.ncbi.nlm.nih.gov/pubmed/36519342
http://dx.doi.org/10.1080/19490976.2022.2155018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757487/
https://www.ncbi.nlm.nih.gov/pubmed/36519342
http://dx.doi.org/10.1080/19490976.2022.2155018

Ejemplares similares